SCHEMBL3482815

SCHEMBL3482815

CC(O)C(=O)OCCCCCCO.O=C(O)CCCCCO

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 7/20 0.55
FFAR1 O14842 3/20 0.55
FFAR4 Q5NUL3 3/20 0.55
ALDH1A1 P00352 3/20 0.48
CAMK2A Q9UQM7 1/20 0.43
TSHR P16473 5/20 0.41
LMNA P02545 1/20 0.41
NFKB1 P19838 1/20 0.41
PMP22 Q01453 1/20 0.41
FNTA P49354 1/20 0.41
FNTB P49356 1/20 0.41
PPARG P37231 6/20 0.39
PPARD Q03181 6/20 0.39
PPARA Q07869 6/20 0.39
HDAC11 Q96DB2 5/20 0.39
TLR2 O60603 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
FABP4 P15090 2/20 0.39
PTPN1 P18031 2/20 0.39
SLC22A6 Q4U2R8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15445476 0.93 ALDH1A1 (0.55) GPR84FFAR1FFAR4ALDH1A1TSHR
SCHEMBL6550919 0.91 ALDH1A1 (0.52) GPR84FFAR1FFAR4ALDH1A1TSHR
SCHEMBL1498093 0.89 ACHE (0.46) ALDH1A1TSHR
SCHEMBL536456 0.89 ACHE (0.46) ALDH1A1TSHR
SCHEMBL1498116 0.89 ACHE (0.46) ALDH1A1TSHR
SCHEMBL3846617 0.89 ACHE (0.46) ALDH1A1TSHR
SCHEMBL3482971 0.89 ACHE (0.46) ALDH1A1TSHR
SCHEMBL6060295 0.87 ACHE (0.43) ALDH1A1
SCHEMBL26381199 0.87 FFAR1 (0.52) GPR84FFAR1FFAR4ALDH1A1CAMK2A
Palmitic Acid SCHEMBL27753195 0.86 GPR84 (0.59) GPR84FFAR1FFAR4ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130345260-A1 High Viscosity Liquid Controlled Delivery System and Medical or Surgical Device DURECT CORPORATION (US) 2013-12-26 US disclosed
US-7833543-B2 Sustained release of active materials; storage stability DURECT CORPORATION (US) 2010-11-16 US disclosed
US-20080152708-A1 High viscosity liquid controlled delivery system and medical or surgical device DURECT CORPORATION 2008-06-26 US disclosed
US-20080145419-A1 High viscosity liquid controlled delivery system and medical or surgical device DURECT CORPORATION 2008-06-19 US disclosed
US-20060210599-A1 Injectable or sprayable nonpolymeric ester or mixed ester solution easily formulated with therapeutic agents GIBSON JOHN W 2006-09-21 US disclosed
US-7053209-B1 High viscosity liquid controlled delivery system and medical or surgical device DURECT CORPORATION (US) 2006-05-30 US disclosed
EP-1212092-B1 HIGH VISCOSITY LIQUID CONTROLLED DELIVERY SYSTEM AND MEDICAL OR SURGICAL DEVICE DURECT CORP (US) 2005-10-26 EP disclosed
WO-2004052336-A2 HIGH VISCOSITY LIQUID CONTROLLED DELIVERY SYSTEM AND MEDICAL OR SURGICAL DEVICE DURECT CORPORATION (US) 2004-06-24 WO disclosed
US-20040101557-A1 High viscosity liquid controlled delivery system and medical or surgical device DURECT CORPORATION 2004-05-27 US disclosed
US-6413536-B1 DELIVERING ACTIVE MATERIALS SOUTHERN BIOSYSTEMS, INC. 2002-07-02 US disclosed
EP-1212092-A2 HIGH VISCOSITY LIQUID CONTROLLED DELIVERY SYSTEM AND MEDICAL OR SURGICAL DEVICE Southern Biosystems, Inc. (US) 2002-06-12 EP disclosed
WO-2001015734-A2 HIGH VISCOSITY LIQUID CONTROLLED DELIVERY SYSTEM AND MEDICAL OR SURGICAL DEVICE SOUTHERN BIOSYSTEMS, INC. (US) 2001-03-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060210599-A1 Injectable or sprayable nonpolymeric ester or mixed ester solution easily formulated with therapeutic agents MMP1, MMP11, MMP13 GPR84 1897/4885FFAR1 1550/4885FFAR4 1303/4885
US-20080152708-A1 High viscosity liquid controlled delivery system and medical or surgical device MMP1, MMP13, MMP9 GPR84 2110/4885FFAR1 4101/4885FFAR4 4370/4885
US-20040101557-A1 High viscosity liquid controlled delivery system and medical or surgical device MMP1, MMP13, MMP9 GPR84 2110/4885FFAR1 4101/4885FFAR4 4370/4885
US-20130345260-A1 High Viscosity Liquid Controlled Delivery System and Medical or Surgical Device MMP1, MMP13, MMP9 GPR84 2124/4885FFAR1 4158/4885FFAR4 4407/4885
US-20080145419-A1 High viscosity liquid controlled delivery system and medical or surgical device MMP1, MMP13, MMP9 GPR84 2110/4885FFAR1 4101/4885FFAR4 4370/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.